United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$188Mraised across 6 rounds since 2005, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
TheranosBiotech/health1 / 24Their pitch deckTheranos's pitch deck, 24 slidesEach slide read for what it argues, against the decks that raised at the same stage.→No investor was named in the report.
From a historical funding record
No investor was named in the report.
From a historical funding recordSEC filing: $45M sold, first sale Jul 2010
ATA Ventures
Continental VenturesFrom a historical funding record
From a historical funding record
From the SEC filings it signed: 1 on the team.
On the board, as filediDaniel Anne WarmenhovenFabrizio Anne BonanniWilliam Anne Foege
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
ATA VenturesContinental VenturesTako VenturesThe Lawrence J. Ellison Revocable TrustMissing a round, or an investor who was in one? Tell us.
Theranos's investors include Draper Fisher Jurvetson (DFJ), ATA Ventures, Continental Ventures, Tako Ventures and The Lawrence J. Ellison Revocable Trust.
Theranos has raised $188M across 6 rounds since 2005. One round did not disclose an amount, so the total is a floor.
Theranos's most recent round was a Debt of $100M in Dec 2017.
Its most recent round, $100M in Dec 2017, is also its largest on record.
Theranos's first round on record, in Feb 2005, was backed by Draper Fisher Jurvetson (DFJ).
Theranos's latest named round is a Debt, in Dec 2017.
Theranos is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
